Avertto is a patented, non-invasive stroke monitoring device for ICU and high-risk patients. In a blinded study, it demonstrated high sensitivity and specificity, detecting all LVO strokes—some days before clinical signs and correlating with clear neurological deterioration. Designed for hospital use, its smart pricing supports rapid adoption, helping prevent stroke before irreversible damage occurs. Avertto makes longer lives worth living.